Abstract
The fluidity of blood is a significant factor for the functioning and maintenance of the microcirculation. In chronic arterial occlusive disease (COAD) the fluidity of erythrocytes is markedly reduced assessed by flow rates through a 5-micrometer pore filter system in simulation of microcirculatory conditions. Risk factors such as heavy smoking, hyperfibrinogenaemia and hypertriglyceridaemia as well as hyperfibrinogenaemia result in flow rates similar to those in patients with COAD. Isolated coagulation phenomena typical for hypercoagulability in such patients produce significantly reduced flow rates and indicate the necessity for therapeutic elimination of risk factors as well as improvement of erythrocyte fluidity, reduction of platelet hyper-reagibility and removal of hypercoagulability. Pentoxifylline effects increases in erythrocyte fluidity, decreases platelet hyper-reactivity and plasmatic hypercoagulability, and improves the fibrinolytic capacity of blood in patients with COAD.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Scandinavian journal of clinical and laboratory investigation. Supplementum
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.